Skip to main content

FDA Approves Lilly’s Foundayo: The New GLP-1 Weight Loss Pill

What is Foundayo?

The FDA has approved Foundayo (orforglipron), making it the second oral GLP-1 medication specifically approved for weight loss. This marks a significant breakthrough for patients who want the benefits of GLP-1 medications without the need for weekly injections.

Shop Medications

,

GLP-1 medications work by mimicking a hormone that helps control blood sugar and appetite. Before Foundayo and the Wegovy (semaglutide) pill, all approved GLP-1 drugs for weight loss came as injections. These 2 recent entries to the market change this by offering the same type of medication in pill form.

The approval is based on results from clinical trials where patients taking Foundayo lost significantly more weight than those taking a placebo pill. This gives people a new option for managing their weight under medical supervision.

How Foundayo Works for Weight Loss

Foundayo contains orforglipron, which belongs to a class of drugs called GLP-1 receptor agonists. These medications copy the action of a natural hormone called GLP-1 that your body makes in your intestines.

When you take Foundayo, it helps your body in several ways. First, it slows down how fast food leaves your stomach. This makes you feel full longer after eating. Second, it affects areas in your brain that control appetite, making you feel less hungry throughout the day.

The medication also helps improve how your body uses insulin, which can be beneficial for people who have both weight concerns and blood sugar issues. However, Foundayo is specifically approved for weight management, not diabetes treatment.

Key Benefits of the New Oral GLP-1 for Weight Loss

The biggest advantage of Foundayo is convenience. Unlike injectable GLP-1 medications such as Wegovy (semaglutide) or Zepbound (tirzepatide), Foundayo can be taken as a daily pill. For people who are uncomfortable with needles or have difficulty with weekly injection schedules, Foundayo offers a more accessible treatment option.

Another major benefit is flexibility in timing. With oral Wegovy,  it must be taken on an empty stomach with a small sip of water, followed by a 30-minute wait before eating, drinking, or taking other medications.

You can take Foundayo at any time of day without worrying about food or water restrictions. This makes it easier to fit into your daily routine compared to Wegovy and other medications that must be taken at specific times or with certain foods.

Clinical Trial Results and Effectiveness

The FDA approval was based on data from clinical trials that tested Foundayo against a placebo in adults with obesity or overweight conditions. It showed significant effectiveness in phase 3 trials (ATTAIN-1), reducing body weight by approximately 12.4% (about 27 pounds) at the highest dose (17.2 mg) over 72 weeks.

The trials also looked at safety and side effects. Researchers found that Foundayo had a side-effect profile similar to other GLP-1 medications, with most issues being mild to moderate digestive problems.

Who Can Take Foundayo

Foundayo is approved for adults with obesity or those who are overweight with at least one weight-related health condition. This might include conditions like high blood pressure, type 2 diabetes, or high cholesterol.

The medication is meant to be used alongside a reduced-calorie diet and increased physical activity. It is not a standalone solution but works best as part of a comprehensive weight management plan.

Your doctor will determine if Foundayo is right for you based on your medical history, current health status, and weight management goals. They will also consider any other medications you take to avoid potential interactions.

Dosing and How to Take Foundayo

Foundayo is taken as a daily oral medication. The specific dosing schedule will be determined by your healthcare provider based on your individual needs and response to treatment.

One of the key advantages is that you can take it at any time during the day. You do not need to worry about taking it with or without food, or avoiding water around the time you take your dose.

Your doctor will likely start you on a lower dose and gradually increase it over time. This helps your body adjust to the medication and reduces the chance of side effects. It is important to take Foundayo exactly as prescribed and not to adjust your dose without talking to your healthcare provider.

Common Side Effects to Expect

Common Side Effects

Like other GLP-1 medications, Foundayo most commonly causes digestive side effects. These typically include nausea, vomiting, diarrhea, and stomach pain. Most people find these effects are strongest when starting the medication and tend to improve as their body adjusts.

Other common side effects may include decreased appetite, constipation, and occasional headaches. These effects are usually mild to moderate and often become less noticeable over time.

Serious but Rare Side Effects

Serious side effects are uncommon but can include inflammation of the pancreas,  severe digestive issues, gallbladder problems, kidney injury from dehydration, low blood sugar (hypoglycemia), serious allergic reactions, and vision changes in patients with type 2 diabetes. These occur in less than 1% of patients but require immediate medical attention if they develop.

Your doctor will monitor you for any serious side effects, especially when you first start taking Foundayo. Contact your healthcare provider right away if you experience severe stomach pain, persistent vomiting, or signs of kidney problems like changes in urination.

How Foundayo Compares to Injectable GLP-1 Medications

The main difference between Foundayo and injectable GLP-1 drugs like Wegovy (semaglutide) or Zepbound (tirzepatide) is the delivery method. While injections are given weekly, Foundayo is taken daily as a pill.

Both pill and injection forms work through similar mechanisms to promote weight loss. However, when it comes to how much weight you can lose, you can expect about 11–12% weight loss with Foundayo, making it less effective than weekly injections like Wegovy (15%) and Zepbound (up to 20–22%).

Injectable GLP-1 medications have been available longer and have more extensive long-term data. However, Foundayo offers the convenience factor that many patients prefer. Your doctor can help you decide which option might work better for your situation.

Cost Considerations and Access

As a newly approved medication, Foundayo may be expensive, especially if insurance coverage is limited. Many insurance plans are still developing coverage policies for new weight management medications.

If you are concerned about cost, there are several strategies to explore. Some patients find that paying cash prices through reliable sources like Universal Drugstore can be more affordable than insurance copays, especially if you have a high-deductible plan.

You can also ask your doctor about manufacturer assistance programs or patient support options that might be available. Working with a pharmacist can help you understand all your options for accessing this medication affordably.

Next Steps if You’re Interested in Foundayo

If you think Foundayo might be right for you, start by talking with your healthcare provider. They can evaluate whether you meet the criteria for GLP-1 therapy and discuss the potential benefits and risks based on your health history.

Come prepared to discuss your weight loss goals, previous attempts at weight management, and any concerns about taking medication. Your doctor will also want to review your current medications and health conditions.

Remember that effective weight management typically involves multiple approaches. Even with Foundayo, you will still need to focus on healthy eating habits and regular physical activity. Your healthcare team can help you develop a comprehensive plan that includes medication along with lifestyle changes.

For more information about weight management medications and how to access them affordably, consider exploring trusted pharmacy resources that can help you understand your options and costs.

References

Related Conditions